Je was op zoek naar: sjukdomsprogress (Zweeds - Engels)

sjukdomsprogress (%)
progressive disease as best overall response (%)

behandlingen fortsatte till sjukdomsprogress.
all treatments were continued until disease progression.

all behandling fortsatte till sjukdomsprogress.
all treatments were continued until disease progression.

behandlingslängd herceptin bör ges till sjukdomsprogress.
duration of treatment herceptin should be administered until progression of disease.

sjukdomsprogress (%) * icke- stratifierat logrank test
response (%) *unstratified logrank test

patienterna behandlades med herceptin till sjukdomsprogress.
patients were treated with herceptin until progression of disease.

behandlingen bör även avbrytas om sjukdomsprogress kan påvisas.
therapy should be discontinued if there is evidence of disease progression.

∗ patienter kan ha haft sjukdomsprogress i multipla organ
*patients may have had multiple sites of disease progression

behandlingen fortsatte tills sjukdomsprogress eller oacceptabel toxicitet.
treatment was given until progressive disease or unacceptable toxicity.

avastin 10 mg/kg gavs varannan vecka tills sjukdomsprogress.
avastin 10 mg/kg was given every 2 weeks until disease progression.

patienter med metastaserad bröstcancer ska behandlas med herceptin till sjukdomsprogress.
patients with mbc should be treated with herceptin until progression of disease.

inklusionskriterierna identifierade patienter som vid studiestart hade evidens för tidig sjukdomsprogress.
the inclusion criteria identified patients who at baseline had evidence of early disease progression.

risken för sjukdomsprogress reducerades med 46 % och risken för återfall med 51 %.
the risk of disease progression was reduced by 46 % and the risk of relapse by 51 %.

tarceva eller placebo intogs oralt en gång dagligen till sjukdomsprogress eller oacceptabel toxicitet.
tarceva or placebo was taken orally once daily until disease progression or unacceptable toxicity.

vid situationer då det krävdes att kemoterapin avslutades tidigt fortsatte behandlingen med avastin i monoterapi till sjukdomsprogress.
in situations where early discontinuation of chemotherapy was required, treatment with avastin as a single agent continued until disease progression.

avastin ges som tillägg till platinabaserad kemoterapi i upp till 6 behandlingscykler följt av avastin som monoterapi tills sjukdomsprogress.
avastin is administered in addition to platinum-based chemotherapy for up to 6 cycles of treatment followed by avastin as a single agent until disease progression.

det rekommenderas att kliniskt stabila patienter med initialt tecken på sjukdomsprogression ska stå kvar på behandling till dess att sjukdomsprogress har bekräftats.
it is recommended to continue treatment for clinically stable patients with initial evidence of disease progression until disease progression is confirmed.

crossover till den andra behandlingsarmen var tillåten om patienterna visade tecken på sjukdomsprogress eller intolerans som inte kunde hanteras med dosjustering.
crossover to the alternative treatment arm was allowed if patients showed evidence of disease progression or intolerance that could not be managed by dose modification.

lokalisationer för progress följande lokalisationer för sjukdomsprogress har påvisats efter behandling med herceptin och paklitaxel vid metastaserad bröstcancer i den pivotala studien:
19 sites of progression after herceptin and paclitaxel therapy for metastatic breast cancer in patients in the pivotal trial the following sites of disease progression were found:

i de avastin-innehållande behandlingsgrupperna kunde patienter få avastin i monoterapi var tredje vecka tills sjukdomsprogress eller oacceptabel toxicitet.
in the avastin-containing arms, patients could receive avastin as a single-agent every 3 weeks until disease progression or unacceptable toxicity.